knowcompoundsNAD(+)
Specimen compound organic compound, cationPlate I
NAD(+)
A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage.
Continue
It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (nadh). (Dorland, 27th ed)”

432 readings, by contour and atom
- Formula
- C21H28N7O14P2+
- Molar mass
- 664.438 g/mol
- ChEBI
- CHEBI:15846
- PubChem CID
- 5893
- MeSH
- D009243
- InChIKey
- BAWFJGJZGIEFAR-NNYOXOHSSA-O
↑ raised
01 · the evidence, ordered
What the evidence says
- Very limited
NAD(+)
5 reference statements, not drawn · 2 compounds on the outer ring, not drawn
Keys
← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it
02 · findings
What NAD(+) moved, and by how much
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
- Left ventricular ejection fractionMoved: raisesEvidence: Very limitedPaper: PMID 429616392026
- Who
- Patients with ST-segment elevation myocardial infarction undergoing primary PCI, all receiving standard medical therapy; LVEF at 30 days
- Dose studied
- intravenous NAD+ 10 mg/day for 7 days
At 30 days, the NAD⁺ group demonstrated a modest but significant improvement in LVEF compared with the placebo group (56.32 ± 8.04% vs. 53.37 ± 8.12%, p = 0.048).”
Quoted verbatim from Effect of Intravenous Nicotinamide Adenine Dinucleotide on Left Ventricular Function After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: A Randomized Controlled Trial.RCT · 7 daysPermalink
No row matches these filters.
No dose is advised.
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
03 · identity
Structure
- Charge
- +1
- SMILES
- NC(=O)c1ccc[n+]([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c1
- Description on record
- The oxidised form of nicotinamide adenine dinucleotide found in all living cells. In metabolism, NAD+ is involved in redox reactions, carrying electrons from one reaction to another.
What the reference databases state
5Reference statements
625Reactions
05 · on the label · 128 products
Labelled products
Source: NIH DSLD · Ingredient: NAD(+) · 128 products · Declared amount per serving: 0.025–1,000 mg
63 labels state an amount65 do not
- 7T PharmaGenicin Vita-Q5 mgper 1 tabletDSLD:263274
- Alive By NatureLSG NAD+250 mgper 2 mLDSLD:230821
- Alive By NatureLSG NAD+250 mgper 2 mLDSLD:230822
- Alive By NaturePure NAD+125 mgper 1 scoopDSLD:230854
- Alive By NatureSublingual Pure NAD+125 mgper 1 tabletDSLD:230852
- Alive By ScienceLIPO NAD+ Complete150 mgper 1 vegetarian capsuleDSLD:264769
- Alive By ScienceNAD+ Micromist25 mgper 2 spraysDSLD:266191
- Allergy Research GroupMitochondrial CofactorsBeta-Nicotinamide Adenine Dinucleotide · reduced B-Nicotinamide Adenine Dinucleotide5 mgper 3 capsulesDSLD:304257
- Applied NutritionLibido-Maxamount not statedper 1 liquid soft-gelDSLD:323143
- Axis Pharmaceutics Inc.VitaXyme5 mgper 1 tabletDSLD:263320
- Axis Pharmaceutics Inc.Vitazyme Tablets5 mgper 1 tabletDSLD:263329
- Axis Pharmaceutics Inc.Vitazyme Tablets5 mgper 1 tabletDSLD:263341
Show the remaining 116Show the first 12
Label record: NIH Office of Dietary Supplements · CC0
06 · the record
Sources
360
papers screened for NAD(+)
- admitted
- 1
- read and discarded
- 140
- not read yet
- 219
Sources cited
1 paper · 1 finding
Show every paper citedHide the papers cited
Other names · 8
β-NAD · Diphosphopyridine nucleotide · DPN · NAD · NAD+ · Nadide · Nicotinamide adenine dinucleotide
systematic · adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate}